Outputs

Home  /  Outputs

The Final Project Plan of the assessment on siponimod is now available. The final assessment report will be published on 7th February, 2020. Please access the Final Project Plan at the following link: PTJA08 Final Project Plan

Patient group input requested for a new Joint Assessment on a medicinal product for neuromyelitis optica spectrum disorders. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have

EUnetHTA is pleased to announce the start of the next Pharmaceutical Joint Assessment. PTJA13 addresses ‘satralizumab indicated for the treatment of patients ≥12 years with neuromyelitis optica spectrum disorders (NMOSD)’, submitted by Roche. We are delighted that INFARMED, EUR (Erasmus

  Patient group input requested for a new Joint Assessment on a medicinal product for acute myeloid leukaemia. EUnetHTA deems patient involvement very important in the production of Joint Assessment reports. We recognise that patients and those who support them have unique